Former French President Nicolas Sarkozy has been stripped of his Legion of Honor medal after he was found guilty of corruption and influence peddling while he was the country’s head ...

Ferrari has won the 24 Hours of Le Mans for the third year running but a late surge from Porsche Penske Motorsport denied the Italian manufacturer a podium sweep. The ...

Health officials say at least eight Palestinians were killed and dozens more wounded in a shooting near Israeli- and U.S.-supported food distribution points in the Gaza Strip. Witnesses said Israeli ...

Indian authorities have started handing over remains of the victims of one of India’s worst aviation disasters after identifying some through DNA tests. The Air India flight crashed shortly after ...

The death toll is rising as Israel and Iran traded missile strikes for a third straight day. Israel on Sunday hit targets in Tehran, including the Defense Ministry and sites ...

San Diego Padres (38-31, third in the NL West) vs. Arizona Diamondbacks (36-34, fourth in the NL West) ...

Taiwan’s Commerce Ministry has added Chinese chipmakers Huawei Technologies and Semiconductor Manufacturing International Corp to its export control list, as trade and technology frictions between the ...

Turkish media are reporting that one person has been killed and 19 injured when two hot air balloons crashed in central Turkey. The private Ilhas News Agency and other outlets ...

South Florida ran a brilliant 1,600-meter relay to close the NCAA men’s outdoor track and field championships Friday night, leaving Southern California and Texas A&M tied ...

Guinea’s military junta has created a new institution that will be responsible for managing elections, including a constitutional referendum in September and the general and presidential elections set ...

A helicopter carrying Hindu pilgrims has crashed in the northern Indian state of Uttarakhand, killing seven people on board. The chopper was flying to Guptkashi, a prominent Hindu pilgrimage site ...

Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy of INCA033989, a novel, first in class, Incyte-discovered, targeted ...